Epidemiological aspects of soft tissue sarcomas (STS) - Consequences for the design of clinical STS trials

Citation
Pha. Nijhuis et al., Epidemiological aspects of soft tissue sarcomas (STS) - Consequences for the design of clinical STS trials, EUR J CANC, 35(12), 1999, pp. 1705-1710
Citations number
24
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
EUROPEAN JOURNAL OF CANCER
ISSN journal
09598049 → ACNP
Volume
35
Issue
12
Year of publication
1999
Pages
1705 - 1710
Database
ISI
SICI code
0959-8049(199911)35:12<1705:EAOSTS>2.0.ZU;2-Y
Abstract
The purpose of the study was to gain insight into epidemiological aspects o f soft tissue sarcomas (STS), based on the population-based cancer registry of the Comprehensive Cancer Center North-Netherlands (CCCN), and to provid e data for the development of future STS clinical trials. 456 primary STS ( Kaposi, urogenital and gastro-intestinal STS excluded), registered from 198 9 to 1995 by the cancer registration of the Comprehensive Cancer Center Nor th-Netherlands (CCCN), were analysed. The annual, age-adjusted, STS inciden ce was 3.6 per 100 000. Incidence increased with age. Half of the patients were over the age of 65 years. Malignant fibrous histiocytomas and liposarc omas were most frequently encountered. At presentation, nodal involvement w as rare (3-8%). Distant metastases were more frequently encountered (9-14%) , and appeared to be related to tumour size and site. Above 70 years of age , 16% of patients received no treatment at all, especially for metastatic d isease. (C) 1999 Elsevier Science Ltd. All rights reserved.